Protective DNA vaccination against myelin oligodendrocyte glycoprotein is overcome by C3d in experimental autoimmune encephalomyelitis
- PMID: 17521729
- DOI: 10.1016/j.molimm.2007.04.008
Protective DNA vaccination against myelin oligodendrocyte glycoprotein is overcome by C3d in experimental autoimmune encephalomyelitis
Abstract
Complement receptor 2 (CR2) and its physiological ligand, C3d, known for its molecular adjuvant property on the immune response, exhibit opposite effects with regard to autoimmunity. Although CR2 has been implicated in maintaining self-tolerance, recent studies reported a role for C3d signaling to CR2 in tolerance breakdown to self-antigens and the initiation of inflammatory autoimmune pathologies. In the present study, we have investigated the effect of C3d in a model of tolerogenic DNA vaccination encoding the myelin oligodendrocyte glycoprotein (MOG-DNA) which protected mice from the induction of an experimental autoimmune encephalomyelitis (EAE). We show that fusing two or three copies of C3d to MOG overcomes the protective effect of DNA vaccination. Multimeric C3d was able to revert the unresponsiveness state of specific T cells induced by MOG-DNA, independently of a modification in the Th1/Th2 cytokine pattern. Interestingly, the adjuvant effect of C3d was not sufficient to boost the anti-MOG antibody response after DNA vaccination. These findings suggest that C3d might be involved in self-tolerance breakdown and could contribute to the pathogenesis of central nervous system autoimmune disorders.
Similar articles
-
C3d binding to the myelin oligodendrocyte glycoprotein results in an exacerbated experimental autoimmune encephalomyelitis.J Immunol. 2007 Mar 1;178(5):3323-31. doi: 10.4049/jimmunol.178.5.3323. J Immunol. 2007. PMID: 17312184
-
Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis.Eur J Immunol. 2000 Dec;30(12):3663-71. doi: 10.1002/1521-4141(200012)30:12<3663::AID-IMMU3663>3.0.CO;2-7. Eur J Immunol. 2000. PMID: 11169409
-
Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response.J Immunol. 2003 Feb 15;170(4):1806-13. doi: 10.4049/jimmunol.170.4.1806. J Immunol. 2003. PMID: 12574345
-
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.Glia. 2001 Nov;36(2):220-34. doi: 10.1002/glia.1111. Glia. 2001. PMID: 11596130 Review.
-
The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.J Neural Transm Suppl. 2000;(58):123-33. doi: 10.1007/978-3-7091-6284-2_10. J Neural Transm Suppl. 2000. PMID: 11128602 Review.
Cited by
-
The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A review.Front Mol Neurosci. 2022 Oct 13;15:1017484. doi: 10.3389/fnmol.2022.1017484. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36311030 Free PMC article. Review.
-
Prophylactic and therapeutic DNA vaccines against Chagas disease.Parasit Vectors. 2015 Feb 24;8:121. doi: 10.1186/s13071-015-0738-0. Parasit Vectors. 2015. PMID: 25885641 Free PMC article. Review.
-
Inhibition of experimental autoimmune encephalomyelitis by tolerance-promoting DNA vaccination focused to dendritic cells.PLoS One. 2018 Feb 6;13(2):e0191927. doi: 10.1371/journal.pone.0191927. eCollection 2018. PLoS One. 2018. PMID: 29408931 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical